Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups
Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643)
12/2005
12/21/2005CN1709851A Clean production method for fenoprofen calcium
12/21/2005CN1709850A DL-amygdalic acid preparing method
12/21/2005CN1709849A Method for synthesizing glyoxalic acid by oxidation of glyoxal with maleuric ozonide
12/15/2005WO2005117854A2 Aryl ketone compounds and compositions for delivering active agents
12/15/2005WO2005097102A3 Method to treat chronic heart failure and/or elevated cholesterol levels
12/15/2005CA2566161A1 Aryl ketone compounds and compositions for delivering active agents
12/14/2005EP1604970A1 2-(Biphenyl-3-yl)-carboxylic acids of gamma-secretase-modulating activity
12/14/2005CN1706789A Alpha, beta-unsaturated ketone compound and its prepn process and GST-Pi inhibiting activity
12/13/2005USRE38921 have strong and selective leukotriene antagonist activity, and are useful for prevention and treatment of allergic diseases such as bronchial asthma
12/08/2005US20050272830 Resinous Michael addition product of a beta-dicarbonyl compound (beta-keto esters, beta-diketones, beta-keto amides, beta-ketoanilides), and a multifunctional (meth)acrylate metallic monomer (calcium or zinc (meth)acrylate; optional reactive diluent such as a Lewis-functional polyacrylate ester
12/08/2005US20050271772 blending calcium as calcium salt and anhydrous citric acid or citric acid monohydrate, melting the blended calcium salt and citric acid, in a low-water environment, to allow formation of the tricalcium citrate; dispersed in a food, in order to fortify the food with calcium
12/07/2005EP1602639A1 Process for production of perfluorodiacyl fluorides
12/07/2005EP1601680A2 Ferric organic compounds, uses thereof and methods of making same
12/07/2005EP1601251A2 Compounds for the treatment of metabolic disorders
12/07/2005EP1355872A4 Process for stereoselective synthesis of prostacyclin derivatives
12/07/2005EP1038524B1 L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof
12/06/2005US6972294 Compounds, their preparation and use
12/01/2005WO2005113506A1 Compounds and compositions as ppar modulators
12/01/2005US20050267206 Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
12/01/2005US20050267183 Selective estrogen receptor modulators
12/01/2005US20050267168 Pentanoic acid derivatives
12/01/2005US20050267167 Pentanoic acid derivatives
12/01/2005US20050267149 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/01/2005CA2564365A1 Compounds and compositions as ppar modulators
11/2005
11/30/2005CN1229324C Extraction process of tanshin general phenolic acid and its prepn and use
11/24/2005WO2005110963A1 (biphenyl-3-yl)-carboxylic acids and derivatives thereof and their use in therapy
11/24/2005US20050261371 Administering valproic acid or salts to treat Alzheimer's disease, amyotrophic lateral sclerosis, multiple sclerosis, stroke, and other nervous system disorders
11/23/2005EP1598334A1 Thyroid hormone analogues and methods for their preparation
11/23/2005EP1597223A2 Hydroxyl compounds and compositions for cholesterol management and related uses
11/23/2005CN1699325A A process for the preparation of 2-chloro-3-(phenylmethoxy)propionic acid potassium salt
11/23/2005CN1228327C Carboxylic acid derivatives and drugs containing the same
11/23/2005CN1228301C Poly epoxy butanedioic acid and its salt preparing method
11/22/2005CA2068066C Herpesvirus particles and vaccine
11/17/2005WO2005108345A1 Synthesis and biological activity or novel bicyclic aba analogs
11/17/2005WO2005108344A1 Radiation-curable coatings for metal substrates from multifunctional acrylate oligomers
11/17/2005WO2005108337A2 Compounds with activity at estrogen receptor
11/17/2005US20050256333 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
11/17/2005US20050256218 Containing a beta-diketone or a beta -ketoester; for example 3-{4-Acetyl-4-[2-(ethoxycarbonyl)ethyl]-5-oxohexanoyloxy}-2,2-dimethylpropyl ethyl 4,4-diacetylheptane-1,7-dioate; use in photocuring of UV curable ethylenically unsaturated compounds; yields colorless products; nonyellowing
11/17/2005US20050256210 Compounds with activity at estrogen receptors
11/17/2005US20050252785 electrochemical oxidation of a monosaccharide in the presence of a carbon-based anode, free of sodium hypochlorite, can generate at least one of the isomers of 2-carboxy-2,3,4-trihydroxypentanedioic acid, or salt and glutaric acid or salt, using tetramethylpentamethylene nitroxide catalyst
11/17/2005CA2566455A1 Synthesis and biological activity of bicyclic aba analogs
11/17/2005CA2565840A1 High yield and rapid syntheses methods for producing metallo-organic salts
11/17/2005CA2565094A1 Compounds with activity at estrogen receptor
11/17/2005CA2565060A1 Radiation-curable coatings for metal substrates from multifunctional acrylate oligomers
11/16/2005EP1594512A2 Compounds for the treatment of viral infection
11/16/2005EP1289517B1 Pharmaceutical compositions comprising cannabidiol derivatives
11/16/2005CN1697821A Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
11/15/2005US6965034 Deoxygenation of epothilone A or B, to form desoxyepothilone used as nontoxic anticarcinogenic agents
11/15/2005US6964983 Compounds that modulate PPAR activity and methods for their preparation
11/10/2005WO2005105773A1 11-methyl-13-tridecanolide, 12-methyl-14-tetradeca- nolide and 13-methyl-15-pentadecanolide, perfume compositions containing the same, and process for the production of compounds including the same
11/10/2005WO2005105764A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005WO2005105736A1 Novel compounds, their preparation and use
11/10/2005WO2005105727A1 Crth2 receptor antagonists
11/10/2005WO2005105726A1 Novel compounds, their preparation and use
11/10/2005WO2005105725A1 Novel compounds, their preparation and use
11/10/2005WO2005105724A1 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/10/2005WO2005105723A1 Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/10/2005WO2005042509A8 7-`(7-alkoxy)-chrom-3-en-6-yl!-heptatrienoic acid and 7-`(3­alkoxy)-5,6-dihydronaphthalen-2-yl!-heptatrienoic acid derivatives modulators
11/10/2005US20050250824 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient
11/10/2005CA2566369A1 Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/10/2005CA2565184A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005CA2563454A1 Crth2 receptor antagonists
11/03/2005WO2005102047A1 Salts of dihydrojasmonic acid and use thereof in agriculture
11/03/2005WO2005080309A8 Stereoselective synthesis of a 4,4-disubstituted cyclohexanepropanoic acid
11/03/2005US20050245602 Selective estrogen receptor modulators
11/02/2005EP1590314A2 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
11/02/2005EP1257524B1 A process for the preparation of salts of l-carnitine and alkanoyl l-carnitine with mucic acid
11/02/2005EP1157000B1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
11/01/2005US6960693 Quaternary ammonium, phosphonium compound
11/01/2005US6960674 A lipoxin compound for treating polymorphoneutrophil (PMN) inflammation
10/2005
10/27/2005WO2005100292A1 New photoinitiators
10/27/2005WO2005099679A1 New double salts of (-)-hydroxycitric acid and a process for preparing the same
10/27/2005WO2005054168A3 A process for resolving, optionally substituted, mandelic acids by salt formation with a chiral base cyclic amide
10/27/2005US20050240041 catalytic hydroxylation of palm based oleic acid with formic acid and hydrogen peroxide to produce 9,10-dihydroxystearic acid; fast preparation, use plant vegetable oils, less expensive and nontoxic; purification; non-irritant, and used in cosmetic products
10/26/2005EP1588999A2 Palm oil-based hydroxy fatty acids
10/26/2005EP1588998A1 A process for the preparation of 2-chloro-3-(phenylmethoxy)propionic acid potassium salt
10/26/2005EP1587779A1 5,6,7,8-tetrahydronaphthalen-2-yl 2,6-difluoroheptatrienoic acid derivatives having serum glucose reducing activity
10/26/2005CN1688532A Composition based on substituted 1, 3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof
10/26/2005CN1686999A 1-carboxy-1-(3, 5-dimethoxy phenyl)-2-(4-R group phenyl) ethano and preparation method thereof
10/26/2005CN1686998A Method for preparing ortho-chloromandelic acid
10/25/2005US6958373 Transformation of polymers to useful chemicals oxidation
10/25/2005US6958145 Synthesis of cyclic compounds
10/20/2005WO2005097102A2 Method to treat chronic heart failure and/or elevated cholesterol levels
10/19/2005EP1586550A1 Lipoxin compounds and their use
10/19/2005EP1585745A1 Fc receptor modulating compounds and compositions
10/19/2005EP1058679B1 Synthesis of epothilones, intermediates thereto and analogues therof
10/19/2005CN1684937A Process for preparing fluorocarboxylic acids
10/19/2005CN1684934A Process for preparing fluorocarboxylic acids
10/19/2005CN1683313A Epoxy sodium succinate and its process for preparing polymer
10/19/2005CN1683312A Process for producing 10-hydroxy capric acid
10/19/2005CN1223564C Intermediate halo phenyl derivatives and their use in process for preparing pyrrole derivatives
10/18/2005US6956138 Method for producing a fluorine-containing compound
10/13/2005WO2005094810A2 Novel pharmaceutical compositions
10/13/2005WO2005058798A8 Compounds having selective cytochrome p450rai-1 or selective cytochrome p450rai-2 inhibitory activity and methods of obtaining the same
10/13/2005CA2562700A1 Novel pharmaceutical compositions
10/12/2005EP1583738A1 Indenoncarboxylic acids derivatives and their use for the treatment of and preventing diabetes and dyslipidaemia
10/12/2005EP1109798B1 Geranic acid derivatives
10/12/2005CN1680270A 3, 4, 5,-substituted benzyl ethylene derivatives and their preparation and use
10/12/2005CN1680269A Process for producing a fluorine-containing compound by liquid phase fluorination
10/12/2005CN1680259A Aspirin-triggered lipid mediators
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 147